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Addiction and Substance Abuse in Nevada*
Introduction
Substance abuse is known to cause a host of problems for individual
users, their communities, and society as a whole. Its cost is
staggering, as measured by lost productivity, medical illness,
serious injuries, and premature death, as well as by resources
required to run criminal justice system and special education
programs (Meara & Frank, 2005). The substance abuse problem is
global in scope. Consider these figures released by the United
Nations’ 2005 World Drug Report[WDR] (United Nations, Office
on Drug and Crime, 2005),











In 2003-2004, about 200 million people, or 5% of the world’s
population age 15-64, had used illicit drugs at least once in the
last 12 months – 15 million more than in 2002-2003.
Many more currently use legal psychoactive substances like
tobacco (about 30% of the world’s adult population) and
alcohol (about 50%).
The number of cannabis (marijuana) users worldwide is now
close to 160 million people or 4% of the population age 15-64.
An estimated 26 million people now use amphetamines and 8
million use ecstasy – a slightly lower figure than the one given
in the previous year’s WDR.
The number of opiate users is estimated to have risen slightly
and now stands at about16 million people worldwide (11
million of which abuse heroin).
The number of cocaine users has grown slightly and is now
estimated to be close to 14 million people (Executive
Summary, U.N. 2005 World Drug Report).

The United States faces serious substance abuse issues of its own.
The 2004 National Survey on Drug Use and Health [NSDUH],
(Substance Abuse and Mental Health Services Administration
[SAMHSA], 2005a), reports the following data:


110 million Americans aged 12 or over (45.8% of the U.S.
population in this age group) used an illicit drug at least once









in their life time. 34.8 million Americans aged 12 or over
(14.5% of the U.S. population in this age group) used an illicit
drug at least once in the previous year.
156.7 million Americans aged 12 years or over (65.1% of the
population in this age group) used alcohol in the last 12
months; 120.9 millions (50.3%) used alcohol in the last
month; 54.7 million (22.8%) engaged in binge drinking
(defined as “five or more drinks on at least one occasion in the
30 days prior to the survey” [p.4]); and 16.7 million (6.9%),
heavy drinking (defined as “binge drinking on 5 or more days
in the past month” [p. 4]).
83.1 million Americans aged 12 years or over (34.5% of the
population in this age group) used tobacco in the past year;
70.3 millions (29.2%) used tobacco in the last month.
25.5 million Americans aged 12 or over (10.6% of the
population in this age group) used marijuana in the last year;
14.6 million (6.1%) used marijuana in the last month.
5.7 million Americans aged 12 or over (2.4% of the population
in this age group) used cocaine in the last 12 months; 1.3
millions (0.5%) used crack; and 0.4 millions (0.2%) used
heroin.

The Silver State has its share of substance abuse problems, as
reported by the 2002-2003 NSDUH data (Wright & Sathe, 2005):






In 2002-2003, 10.3% of Nevadans 12 or older reported using
an illicit drug in the last month. Among the respondents in the
12-17 age-group, 12.5% used; in the 18-25 age-group, 22.0%
used; and 8.2% of the 26 or older respondents used.
50.7% of Nevadans who are 12 or older reported using alcohol
in past month. In the 12-17 age-group, 18.4% used; in the
18-25 age-group, 56.4% used; and in the 26 or older group,
54.1% used.
35.0% of Nevadans who are 12 or older reported using any
tobacco product in past month. In the 12-17 group, 15.3%
used; in the 18-25 group, 42.4% used; and in the 26 or older
group, 36.5% used.





7.6% of 12 or older Nevadans reported using marijuana in the
last month. In the 12-17 age-group, 9.6% used; in the 18-25
group, 18.3% used; and 5.7% of those 26 or older used.
2.4% of 12 or older Nevadans reported using cocaine in past
year. In the 12-17 age-group, 2.0% used cocaine; 7.4% of the
18-25 group and 1.7% of those 26 or older used cocaine in
past year (See Appendix 2 for further details).

Scholars proposed different theories explaining why people abuse,
or become addicted to, substances. The moral approach is based on
the notion that substance abuse is a personal choice and that an
addict is simply an irresponsible person. Biological theory, on the
other hand, assumes that addiction is hereditary, that people
become addicts because they are so predisposed, and that that
substance abuse is, consequently, a disease. Psychological theory
links addiction to a certain personality type and treats substance
abuse as a form of self-medication that helps the individual control
depression and anxiety. Sociological theory blames society for drug
abuse, citing in particular limited opportunities available to certain
social groups and focusing on subcultures that condone drug use.
Finally, the multivariate theory, also known as bio-psycho-social
theory, is based on the premise that addiction stems from multiple
factors, that these factors may include biological
predisposition,psychological stress, family and community
environment, as well as social deprivation (Fishbein & Pease, 1996;
Fisher & Harrison, 2005).
The present report will review the substance abuse patterns in
Nevada, place the state’s record in the national context, provide a
cross-county comparison (where data is available), discuss the
substance abuse treatment in the state, and highlight the
community resources available to Nevadans confronting addiction
and drug dependency problems.
Historical Overview
Federal efforts to control illicit drugs in the U.S. go back to the early
20th century when the government sought to limit the import of
opium and cocoa in response to the growing abuse of these
substances. In 1914, U.S. Congress adopted the Harrison Narcotic

Act that sought to cut down illegal manufacture, sales, and
prescriptions of narcotics. The Harrison Act was replaced by the
1970 Controlled Substance Act (CSA) designed to control access to
drugs used for recreational purposes as well substances taken by
athletes to improve their performance. The CSA is the legal
foundation for regulating drug and other substance manufacture
and distribution in the U.S. ( U.S. Drug Enforcement Administration
[DEA], 2005). While the Food and Drug Administration (FDA)
defines which drugs require prescription, the Drug Enforcement
Administration (DEA) designates controlled substances – the drugs
that cannot be manufactured and sold without a license and
dispensed without prescription. The DEA also registers organizations
and individuals authorized to write prescriptions.
The 1970 CSA classified drugs into five categories based on criteria
such as their potential for abuse, whether the drug has accepted
medical use, etc. A Schedule I drug (e.g., heroin) is classified as
having high potential for abuse and no currently accepted medical
use in treatment. Schedule II drugs (e.g., morphine) include
substances with high potential for abuse but also having an
accepted medical treatment value. Schedule III drugs (e.g.,
anabolic steroids) are determined to have less potential for abuse
than Schedule I or II drugs and are currently accepted as a
medically useful substance. Schedule IV drugs are medicinal
substances with acceptable therapeutic use. They have less
potential for abuse and dependence than Schedule III drugs. The
Schedule V drugs are medicinal drugs with accepted therapeutic use
and the lowest potential for abuse or dependence (U.S. DEA, 2005).
Nevada has taken measured steps to comply with the federal laws
and offer rehabilitation to people with addictions. Chapter 458 of the
Nevada Revised Statutes and Chapter 458 of the Nevada
Administrative Code cover “Abuse of Alcohol and Drugs” and provide
formal definitions of relevant terms. The Nevada Revised Statutes
charge the Health Division with the responsibility of formulating and
operating a comprehensive state plan for drug abuse programs,
planning and certifying addiction treatment facilities and programs,
and allocating and using funds for drug abuse treatment purposes.

Chapter 458 of the Nevada Administrative Code offers further
guidelines and regulations for alcohol and drug abuse programs.
This code spells out the information that must be included in a
treatment program’s policy and drug court program’s manuals and
the services that must be offered to clients, including procedures for
determining substance-related and mental health disorders. The
code also specifies the qualifications required for a professional
conducting addiction assessment as well as proper way of recording
the assessment results.
While Nevada has made strides in confronting drug abuse problems
among its citizens, the state’s records remain uneven. According to
the 2002-2003 NSDUH(Wright & Sathe, 2005), which divides all
states into five-tiers with the 5 th tier containing 10 states (or D.C.)
with the worst indicators and the 1 st tier listing 10 states (or D.C.)
with the best records,


Nevada placed in the 4 thor second-worst tier in the nation for
its “alcohol dependence or abuse in past year,” middle or 3 rd
tier for “any illicit drug dependence or abuse in past year,” and
the worst or 5 th tier for its “tobacco products and cigarettes
use in past month” in the years 2002-2003.

According to SAMHSA’s (1992-2004) TEDS, distributions of primary
drug at treatment admission have changed in Nevada since 1992:







The situation is most worrisome with Methamphetamine/
Amphetamines (MA/A) – the leading illicit drug at treatment
admission in Nevada since 1994. MA/A use in Nevada has
increased from about 5% of all admissions in 1992 to 17.8% in
1994, and to 29% in 2004. (See Table 2 for detailed
information).
Marijuana has increased double, from 6.2% of all admissions
in 1992 to 12.4% in 2004.
The “alcohol only” category has decreased from 35.5% in 1992
to 26.8% in 2002 and 26.7% in 2004 of all admissions. This is
consistent with the national trend which shows a comparable
drop from 37.2% in 1992 to 23.6% in 2002.
Smoked cocaine admissions have decreased from 11.9% in
1992 to 7.9% in 2002 and 7.6% in 2004. Again, this is in

keeping with the national trend which registered a decrease
from 11.9% in 1992 to 9.4% in 2002.
According to U.S. Sentencing Commission (2003),




In fiscal year 2003, the overall drug-related cases accounted
for 15.2% of all federally-sentenced cases in Nevada,
exceeded by immigration (26.6%) and firearms (20.1%).
Nationally, drug-related cases make up the largest portion of
all federally-sentenced cases (37.4%), followed by immigration
(21.9%) and fraud (10.8%).

Treatment outreach and availability are two areas where the nation
as a whole and the state of Nevada are lagging behind the
documented needs. According to the 2002, 2002-2003, and 2004
NSDUH data (SAMHSA, 2005b;Wright, 2004; Wright & Sathe,
2005),




In 2004, 23.5 million people nationwide needed AOD
treatment, but only 2.3 million people received treatment at
an AOD specialty facility. (Note: The 2004 NSDUH defined a
person “needing treatment” as the individual who met the
Diagnostic Statistical Manual IV (DSM-IV) criteria for alcohol or
illicit drug dependence or abuse in the past 12 months, or as
the individual who received alcohol and/or other drug specialty
treatment in the past 12 months (American Psychiatric
Association, 1994).
When it comes to the treatment gap, Nevada ranked in the
worst tier for illicit drug use in 2002; 3.0% of Nevadans
needed but did not receive treatment for illicit drug use in the
past year. Nevada moved to the middle tier in 2002-2003, with
a rate of 2.7% (95% prediction interval: 2.3%-3.85%, 2.193.31%, respectively). The trend was the opposite in the
alcohol abuse category where the treatment gap appears to
have increased. Nevada scored in the 3rd tier in 2002,
indicating 7.6% of Nevadans needed but did not receive
treatment for alcohol use in the past year. Nevada appeared to
regress to the 4th tier in 2002-2003, showing 7.8% of
Nevadans needed but did not receive treatment for alcohol use



(95% prediction interval: 5.98%-9.63%, 6.49%-9.4%,
respectively).
According to 2004 data, 94.2% of Americans who needed, but
did not receive, AOD treatment “did not feel they needed
treatment.” On the other hand, 42.5% of Americans who
needed, “felt they needed,” and made an effort to get, but did
not get, treatment cited “cost/insurance barriers” as a primary
reason why they could not obtain treatment.

Drug addiction requires prompt attention, especially when underage
individuals are involved. To devise effective strategies of countering
illicit drug use, we need to take a closer look at the research
findings and statistics in key drug abuse categories.
Current Trends in Substance Dependence and Abuse in
Nevada
Please note that “alcohol dependence or abuse” and “any illicit drug
dependence or abuse” are defined by NSDUH as meeting the criteria
of DSM-IV (American Psychiatric Association, 1994)
Alcohol Dependence or Abuse
According to the 2002-2003 NSDUH data (Wright & Sathe, 2005),






7.6% of Americans 12 or older met the criteria for alcohol
dependence or abuse in past year. Among the 12-17 age
group, 5.9 met the criteria; among the 18-25 age group,
17.4% met the criteria; and among the 26 or older group,
6.1% met the criteria.
Nevada’s rate for “alcohol dependence or abuse in past year”
was 8.01%, slightly higher than the national rate of 7.6%.
Among the 12-17 age group, 6.9% met such criteria; among
the 18-25 age group, 16.2% met such criteria; and among the
26 or older group, 6.9% met such criteria.
Nevada found itself in the 4th tier in the “alcohol dependence
or abuse in past year” category i.e., the Silver State was
among the 10 states with the second highest dependency rate
in the nation.





Among the 10 states with the worst records (those placed in
the 5th tier) were North Dakota (10.8%), South Dakota
(10.8%), Montana (10.7%), and Nebraska (10.2%).
States with the best indicators included Alabama (6.1%),
Kentucky (6.2%), New Jersey (6.3%), and Mississippi (6.5%).

Illicit Drug Dependence or Abuse
Nevada faired better in the category of “any illicit drug dependence
or abuse.” According to the 2002-2003 NSDUH data (Wright &
Sathe, 2005),









9.2% of Americans 12 or older met the criteria for any illicit
drug dependence or abuse in past year. Among the 12-17
agegroup, 8.9% met the criteria; among the 18-25 age group,
21.4% met the criteria; and among the 26 or older group,
7.2% met the criteria.
3.0% of Nevadan who are 12 or older met the criteria for any
illicit drug dependence or abuse in past year. Among the 12-17
age group, 5.98% met such criteria; among the 18-25 age
group, 8.0% met such criteria; and among the 26 or older
group, 1.8% met such criteria.
Nevada placed in the 3rd tier nationwide when all illicit drug
use in a previous year was counted, with its rate of 2.98%
slightly exceeding the national rate of 2.95%.
States and districts in the 5th tier included D.C. (4.0%), Rhode
Island (3.9%), and New Mexico (3.8%).
Among the 4th tier states in this category were Montana
(3.2%) and Oregon (3.1%), while the best performers
included Kansas (2.5%), Iowa (2.5%), Pennsylvania (2.6%),
and Wyoming (2.6%).

Tobacco Products and Cigarettes
Nevada ranked among the 10 states with the highest rate of
tobacco product or cigarette use in the nation.


According to 2002-2003 NSDUH data, the average national
rate of tobacco product use in a previous month was about







30.1% and the average rate of cigarette use was about
25.7%.
Nevada was among 10 States in the worst tier of tobacco use,
with a rate of 35.0% and cigarette use, with a rate of 30.5%.
Yet, it was the only state from the West with such a poor
ranking (most states in the 5th tier were from the South).
Although the Silver State placed in the worst tier (5th tier),
only Nevadans in the age group 26 or over fell into the 5th tier
compared to the corresponding age group nationwide. Nevada
adolescents were ranked in the 2nd tier and young adults aged
18-25 were ranked in the 1 st tier compared to their peers
nationwide. Therefore, the high national ranking of tobacco
products and cigarettes use appears to apply more to
Nevadans aged 26 or older than to Nevadans who were 25 or
younger.
Some States (e.g., Arkansas and Kentucky) in the worst tier of
using tobacco products or cigarettes had all three age groups
(12-17, 18-25, and 26 or older) ranked among the worst tiers
compared to the corresponding age groups nationwide.

Cross-County Comparisons
The Nevada BADA compiled cross-county data for 2001 that shows
patterns of drug dependency and abuse for key geographical
regions in Nevada – Clark County, Washoe County, and Rural
Nevada, plus Carson City (Canfield, Towle, & Gibbs, 2003).




All four Nevada regions had methamphetamine/amphetamine
(MA/A) as their second leading drug at admission, with alcohol
ranking first. MA/A accounted for 22.4% of all admissions in
Clark County, 29.1% in Washoe County, 27.4% in the Rural
Nevada, and 17.9% in Carson City. The Clark County MA/A
admission rate was lower than the Washoe County and Rural
Nevada.
Clark County’s cocaine use rate as measured by admissions
was higher than in the other two geographical areas. Cocaine
figured in 18.0% of all the admissions in Clark County, 9.3% in
Washoe County, and 2.31% in the Rural Nevada (see Table 3
for details).

One possible explanation for this disparity is that, in Clark County, a
higher percentage of admission involved African Americans, and as
the research in this area suggests, African Americans use cocaine
more frequently than MA/A. African American accounted for 20.1%
of all admissions in Clark County and 5.3% in Washoe County.
Addiction in Different Demographic Groups
Gender
According to SAMHSA’s (2002-2004) TEDS, although more men
have substance abuse treatment admissions, both nationally and in
Nevada, the Nevada women tended to have a higher rate for
amphetamines abuse than women nationwide.






The Nevada women have a slightly higher rate of
amphetamine abuse at admission than the Nevadan men,
while the national data show more men than women are
involved with the drug.
Women accounted for 35% of all the treatment admissions in
Nevada in 2004. Yet, they made up 50.9% of all the
amphetamines admissions .
The 2002 rates for women were 35.6% for all admissions and
51.3% for amphetamines admissions. Nationally, the 2002
rates for women were 30.1% and 44.6%, respectively.

Pregnant women and teenage girls in Nevada are particularly
susceptible to MA/A abuse. According to BADA’s 2004 Annual Report
(Towle, Bailey, & Gibbs, 2004),






MA is the leading drug among the pregnant Nevada women
served by BADA’s funded providers at admission, accounting
for 62% of the total drug dependency in this group.
A distant second most abused substance among pregnant
women in Nevada is marijuana and Hashish (14%), followed
by cocaine/crack (10%), alcohol (9%), heroin/morphine (4%),
and other (2%).
Among the adjudicated youth aged 12-18 who were assessed
as having substance abuse problems and referred to
WestCare’s AOD treatment program, 52% of the females

reported methamphetamine to be their drug of choice,
compared to 14% of the males (Steinberg, 2005).
Nevada women accounted for a higher percentage of total
treatment admissions than women nationwide. According to
SAMHSA’s (2002-2004) TEDS,




In 2002, men accounted for 69.8% and women for 30.1% of
all AOD treatment admissions nationwide. The figures were
64.4% and 35.6% respectively for Nevada.
In 2003, the Nevada figures in the same categories were
62.7% and 37.3%, and in 2004, 65% and 35% respectively.
(The national figures for 2003 and 2004 are not available at
this time).

According to the BADA Annual Report (Towle, et al., 2004).




In 2003, Nevadan men represented 64% of the total
population served by BADA-funded providers and women
represented 36%.
Pregnant women in Nevada accounted for 8.2% of all the
women served by BADA-funded providers in 2003.

In several drug abuse categories, Nevada women faired worse than
U.S. women as a whole. According to SAMHSA’s (2002-2004) TEDS,




In 2002, American women exceeded men in only one category
of primary substance abuse at admission – the category of
“sedatives” (51.2% of women versus 48.8 % of men).
Nevada women faired worse than Nevada men in six
categories: sedatives – 77.8% vs. 22.2% (n=9 [9 persons
total]), tranquilizers – 88.2% vs. 11.8% (n=17), other
stimulants – 83.3% vs. 16.7% (n=6), amphetamines – 51.3%
vs. 48.7% (n=2,831), PCP – 75% vs. 25% (n=32), and other
opiates – 67.3% vs. 32.7% (n=107).

Even after excluding two categories that had a small total admission
number (i.e., “other stimulants” and “sedatives”), Nevada women
still outweighed Nevadan men in four categories.













Such a gender-skewed distribution has been observed since
2002 among three of the four above-mentioned drug
categories: tranquilizers, amphetamines, and PCP.
In 2003, Nevada women made up 55% of all tranquilizer users
(n=20), 52.6% of amphetamines users (n=3,253), and 51%
of PCP users (n=51).
In 2004, Nevadan women made up 57.1% of all tranquilizer
users (n=21), 50.9% of amphetamines (n=3,290), and 65.5%
of PCP users (n=29).
Nevada women outweighed Nevada men for “other opiates” in
2003 (53.6% of a total 233 persons), but were outweighed by
Nevada men in 2004 (44.7% vs. 55.3% of a total 295
persons).
Nevada men showed higher rates of drug abuse in other drug
categories, where the gender ratio was, on average, close to
2/3 for men.
The 2004 data showed the following gender ratios: alcohol
only (75.2% vs. 24.8%), alcohol with secondary drug (73.6%
vs. 26.4%), smoked cocaine (71.2% vs. 35.5%), cocaine
consumed in other ways (71.2% vs. 28.8%), marijuana
(71.9% vs. 28.1%), heroin (68.2% vs. 31.8%), and
hallucinogens (66.7% vs. 33.3%).

Children and Youth
Nevada youth have higher rates of drug abuse and addiction than
youth nationwide, as measured by percentages accounted for
among all of the State’s AOD admissions. The SAMHSA (2002 –
2004) TEDS findings show:


In 2002, adolescents (12-17 years old) made up 8.3% of all
the AOD treatment admissions in the nation and 12.3% in
Nevada . The 2003 figure for Nevada was 11.6% and 2004
figure was 11.3% (The national figures for 2003 and 2004 are
not available at this time).

Marijuana, MA/A, and alcohol are three major substance abuse
categories among the Nevada youths. According to the Nevada
BADA Annual Report (Towle, et al., 2004),



The top drug of choice among all adolescents at admissions to
BADA-funded providers was marijuana/hashish (48%),
followed by MA/A (26%), alcohol (22%), cocaine/crack (2%)
and other (2%). For Nevada adults, the top drug of choice at
admission was alcohol (43%), followed by MA/A (30%),
cocaine/crack (11%), marijuana/hashish (8%),
heroin/morphine (6%), and other (2%).

Nevada youth had a higher prevalence and incidence (new users) of
marijuana use compared to youth nationwide. According to the
2002-2003 NSDUH data (Wright & Sathe, 2005),








19.7% of Nevada youth reported “marijuana use in past year”
(95% prediction interval: 16.87%-22.81%), whereas 15.4% of
youth nationwide reported such use.
Compared to youth nationwide, Nevada adolescents ranked in
the 5th tier in the “marijuana use in past year” category.
Compared to all Americans, Nevadans 12 or older were ranked
in the 4th tier, the group with the second-highest rates of use.
8.4% of Nevada youth reported “first use of marijuana” (95%
prediction interval: 7.00%-10.11%), whereas 6.6% of youth
nationwide reported such use.
Compared to youth nationwide, Nevada youth were among the
10 States with the highest rate of “first use of marijuana” or
new users (i.e., incidence of marijuana use).

According to the SAMHSA (2002 – 2004) TEDS,




In 2002 in Nevada, those in the 12-17 age group made up
49.7% of all the marijuana admissions, followed by the 21-25
years old, who made up 15.5% of the total, and 18-20 years
old who accounted for 9.5% of the total. Nationwide figures
were 34.6% for the age group 12-17, 19.6% for 21-25, and
16.1% for 18-20 years old.
Adolescents accounted for 44.6% of all the marijuana
admissions in Nevada in 2004 and 47.4% in 2003 (The
national figures for 2003 and 2004 are not available at this
time).

MA/A is also a major drug category among Nevada youth. The
Nevada BADA findings (Towle, et al., 2004) show that





MA is the second leading substance (26%) at admission among
the Nevadan adolescents.
The age group distribution among amphetamines admissions
in Nevada in 2004 were 9.3% for the youth (aged 12-17),
29.1% for the 18-25 age group, and 61.6% for those aged 26
or older. The rates in Nevada in 2002 were 9.3%, 27.1%, and
63.6% respectively. The nationwide rates in 2002 were 4.8%,
28.4%, and 66.8% respectively.
Although youth in Nevada followed the national trend insofar
as they were the smallest age group in amphetamine
admissions, their rate was nearly double that of the national
youth.

Alcohol dependence or abuse is another major problem for Nevada
youth. The 2002-2003 NSDUH data (Wright & Sathe, 2005) show,


The average rate of youth aged 12-17 nationwide who were
classified with alcohol dependence or abuse in the past year
was 5.9 %. The rate for Nevada youth was 6.9% (95%
prediction interval: 5.36%-8.91%), which was lower than the
rates of 13 States (e.g., Montana and North Dakota) and
higher than the rates of 37 states (e.g., D.C., Mississippi,
South Carolina, and Utah). Compared to youth nationwide,
Nevada youth were ranked in the 4th tier.

Tobacco product or cigarette use was less of an issue in the
nationwide ranking for Nevada youth.


Although Nevada was ranked in the top 10 States (5th tier)
with the highest rate of tobacco and cigarette use (past month
use) in 2002-2003, this applies primarily to people aged 26 or
older. Nevada adolescents were ranked in the 2 nd tier and
young adults aged 18-25 were ranked in the 1 st tier.

With regard to the AOD treatment access, Nevada adolescents were
ranked in the 4th tier (the second-worst):



The NSDUH 2002 data (Wright, 2004) show that 6.1% of
Nevada youth were “reporting needing but not receiving
treatment for illicit drug use in the past year,” versus 5.1% of
youth nationwide were. Nevada youth were ranked in the 5
thtier for this category.



Although the rate improved in 2002-2003, Nevada youth were
still ranked in the second-worst tier nationwide. Among the
Nevada youth, 5.4% were still “reporting needing but not
receiving treatment for illicit drug use in the past year,” (95%
prediction interval: 4.09%-7.1%) compared to the national
rate of 4.3%.
With regard to the alcohol treatment gap (people needing but
not receive alcohol use treatment), Nevada youth have been
consistently ranked in the second-worst tier nationwide. In
2002, the State and national figures were 6.1% and 5.6%
respectively and in 2002-2003, 6.8% and 5.6% respectively
(Wright, 2004; Wright & Sathe, 2005).



Meth: One of Nevada’s Major Drug Abuse Problems
Amphetamines are synthetic stimulants that were first commercially
used in U.S. in 1930s to treat medical problems such as narcolepsy
and asthma. Later, World War II soldiers were given the compound
to fight fatigue. Amphetaminesbecame popular in the 1950’s among
students and truck drivers struggling to stay awake after a long
day’s work. Amphetamines were also widely prescribed at the time
to patients with obesity and depression problems ( Center for
Substance Abuse Treatment [CSAT], 1999; Anglin, Burke,
Perrochet, Stamper, & Dawud-Noursi, 2000). At first perceived as a
benign substance, amphetamines came under close scrutiny by
federal authorities as a substance prone to serious abuse. The U.S.
Congress passed several legislative acts in the 1960’s and 1970’s
designed to tighten control over amphetamine production and
distribution due to the drug’s addictive potential (Hohman, et al.,
2004, p. 374). “Initially thought to be a relatively benign drug,
problems from its use in the 1960s and 1970s led to federal
legislation that severely restricted legal production” (Hohman, et al.,
2004, p. 374).

MA (Methamphetamine), which is more potent than amphetamine,
is a derivative of amphetamines, and its potential for abuse is even
greater than that of its parent compound. The Control Substance
Act of 1970 (CSA) classified MA/A as a Schedule II drug, defined as
a substance with high potential for abuse but an accepted medical
use in treatment (U.S. DEA, 2005).
The CSA was not successful in eradicating MA use (CSAT, 1999).
The CSAT experts cited several reasons why earlier measures failed
to stem the tide of MA abuse.









Manufacturing MA is inexpensive, and the ingredients are easy
to obtain.
The production of MA is relatively easy. As experts point out,
“Creative ‘mom and pop chemists’ can now download the
formula for MA from the Internet and produce small quantities
for personal and associate use” (Rawson, Gonzales, and
Brethen 2002, p.145).
Clandestine manufacturers found loopholes in the law, devising
ever new methods of MA manufacturing to escape the law’s
provisions.
MA has a longer effect than cocaine but is less expensive. MA
users typically pay only 25% of what the cocaine users do to
get the drug.
Rawson, Gonzales, and Brethen (2002) cited a United Nation
report, indicating that there were 35 million people worldwide
using or abusing MA/A regularly, compared to 15 million
cocaine users and less than 10 million heroin users. Even
though MA addiction is still more prevalent in the Southwest,
West Coast area, and Hawaii, MA/A has started to invade the
Midwest and some Southern regions of the U.S. (Towle, et al.,
2004). The high prevalence in these regions may have to do
with the fact that the chemicals used to produce MA
(ephedrine and pseudoephedrine) were easy to acquire in
Mexico (Hohman, et al., 2004).

In his testimony before the United States Senate Subcommittee on
Labor, Health and Human Services, Education and Related Agencies,
WestCare Foundation President Richard Steinberg (2005) singled

out Nevada as a test case for the MA abuse. He pointed out that
“athletes and students sometimes begin using meth because of the
initial heightened physical and mental performance the drug
produces. Blue collar and service workers may use the drug to work
extra shifts, while young women often begin using meth to lose
weight. Others use meth recreationally to stay energized at ‘rave’
parties or other social activities” (pp. 1-2). Studies show that
women may use MA to help them do an extra job, take care of their
small children, and complete house chores (Irwin 1995; Joe 1995).
Cretzmeyer, Sarrazin, Huber, Block, and Hall (2003) cited a study
done in Iowa showing that the strongest reason women used MA
was its availability, followed by their wanting to be more productive.
The strongest reason men used MA was also its availability, followed
by curiosity.
The rise of MA abuse in the 1990’s has caught legislators’ attention,
and in 1996, the U.S. Congress unanimously passed the
Methamphetamine Control Act. This Act instituted new controls over
the key ingredients for MA production and toughens criminal
penalties for manufacturing, distribution, and possession of the
drug.
The impact of MA/A abuse is multi-fold. It affects person’s physical
and mental conditions, stimulates drug-related crimes, and spurs
drug-related child maltreatment. The symptoms and side-effects
observed in habitual MA users are as follows:






MA is highly addictive. Prolonged MAuse results in the
increased substance tolerance, requiring ever greater amounts
of the drug to produce the same effect (Rawson, et al., 2002).
The continued use of MA results in sleep deprivation, which
impairs cognitive abilities and causes wide mood swings. In
some cases, the addict becomes extremely paranoid, irritable,
and fatigued (Cretzmeyer, et al., 2003; Rawson, et al.).
The most detrimental side effects of MAabuse include
insomnia, high body temperature, stroke, cardiac arrhythmia,
shaking, stomach cramps, anxiety, paranoid hallucination,
poor coping abilities, and a disorganized lifestyle.





MA addicts are known to be violent and susceptible to
unpredictable outbursts (Cretzmeyer, et al.; Rawson, et al.;
Cohen, Dickow, and Horner, 2003).
Prolonged MA use results in the increased substance tolerance,
requiring ever greater amounts of the drug to produce the
same effect (Rawson, et al.).

MA/A is one of the leading drugs related to crimes in Nevada,
according to U.S. Sentencing Commission (2003),






MA accounted for just over half of all the drug-related
sentencing in Nevada (51.4%), and it was the leading drug
used in all the federally-sentenced drug cases in Nevada
during 2002-2003.
Following MA, the substance that figured most prominently in
the fiscal year 2003 Nevada sentencing was crack cocaine
(15.0%), followed by powder cocaine (11.2%), other (8.4%),
heroin (7.5%), and marijuana (6.5%).
Nationwide, the leading drug related to federally-sentenced
cases was marijuana (26.2%), powder cocaine (23.1%), crack
cocaine (20.7%), MA (17.1%), heroin (7.1%), and other
(5.8%).

For over 60% of Nevada pregnant women served by the Nevada
BADA funded providers, MA was the primary drug of choice (Towle,
et al., 2004). This extremely high rate calls for finelycalibrated
provisions of gender/pregnancy/drug-specific treatment and service
for the pregnant women and their offspring. Such treatment and
services should be provided not only during pregnancy but also after
the baby is delivered. The negative impact of MA on children
manifests itself in several ways:




MA adversely affects an exposed fetus. The MA exposed
neonates may experience growth retardation and premature
birth (Lucas, 1997; Smith, Yonekura, Wallace, Berman, Kuo, &
Berkowitz, 2003).
Sun (2004) summarized various studies suggesting that the
negative consequences of prenatal drug-exposure are often
compounded by the baby’s impoverishing and dysfunctional
postnatal environment.







Children of MA users are known to face higher risks of being
neglected or abused.
Chronic MA users often experience sleep deprivation, which
severely undercuts parents’ ability to tend for their children.
The MA production laboratories, particularly the home labs,
may expose children and adults to a toxic environment,
resulting in short- and long-term health problems (Hohman, et
al., 2004).
MA is particularly dangerous if ingested by children. Some
home labs may recruit teens in MA manufacture and delivery,
leading to a higher MA use among teens (Cretzmeyer, et al.;
Hohman, et al.).

Treatment Needs and Availability
As mentioned earlier, the 2004 NSDUH defined a person “needing
treatment” as the individual who met the DSM-IV criteria for AOD
dependence or abuse in the past 12 months, or as the individual
who received alcohol and/or other drug specialty treatment in the
past 12 months. The 2004 NSDUH provided data on the populations
“receiving any treatment” and “receiving specialty treatment.”
Those receiving any treatment are defined as individuals treated for
an AOD related problem, including emergency room, private
doctor’s office, prison or jail, hospital inpatient, mental health
center, inpatient or outpatient rehabilitation, and self-help group.
Those receiving specialty treatment include individuals treated at a
specialty facility, such as hospitals (inpatient), AOD rehabilitation
facilities (inpatient or outpatient), or mental health centers.
Specialty treatment excludes services offered at an emergency
room, private doctor’s office, self-help groups, prison or jail, and
hospitals on the outpatient basis.
It is critically important to analyze the national and state data on
persons needing and receiving treatment (NT), persons needing and
receiving treatment (NRT), and persons needing but not receiving
treatment (NNRT). The 2004 NSDUH estimates (SAMHSA, 2005a,
2005b) show that nationwide,







There were 23.5 million persons 12 or older (about 9.8% of
the total U.S. population) who needed treatment for an illicit
drug or alcohol use problem.
Of the 23.5 million Americans needing AOD treatment, only
3.8 million people (about 16.2% of the 23.5 million people)
obtained “any treatment,” and only 2.3 million people (about
9.9% of the 23.5 million people) received AOD “specialty
treatment.”
This means that nationwide more than 80% of the people who
needed AOD treatment did not receive it, and about 90% of
the persons who needed AOD treatment did not receive the
AOD specialty treatment.

The 2002-2003 NSDUH State-level data (Wright & Sathe, 2005)
show (Note: the 2004 State-level data are not available at this
time):








Nevada was ranked the 3rd (middle) tier for NNRT for illicit
drug use, with a rate of 2.7%, showing 2.7% of Nevadans
needed but did not receive treatment for illicit drug use (95%
prediction interval: 2.19%-3.31%).
Nationwide, New Mexico had the highest rate of NNRT persons
for illicit drug use (3.5%) and Kansas had the lowest rate
(2.2%) (Note: refer to Wright & Sathe [2005] for 95%
prediction interval for each rate).
Nevada was ranked the 4th tier (the second-worst) for NNRT
for alcohol use, showing 7.8% of Nevadans needed but did not
receive treatment for alcohol use (95% prediction interval:
6.49%-9.4%).
Nationwide, Montana had the highest rate (10.0%) for NNRT
for alcohol use and Tennessee had the lowest rate (5.7%)
(Note: refer to Wright & Sathe [2005] for 95% prediction
interval for each rate).

The main reason people who need treatment but do not receive it
(the NNRT population) give for their situation is that they “did not
feel they needed treatment.”


The 2004 NSDUH data (SAMHSA, 2005a) show that
nationwide, there were 21.1 million people who needed but did

not receive treatment for illicit drug or alcohol use. Among
them, 94.2% did not feel they needed treatment, 3.7% “felt
they needed treatment and did not make an effort,” and 2.1%
“felt they needed treatment and did make an effort.”
Research shows multiple factors that determine why people who
need treatment (who met the DSM IV criteria) but did not feel or
realize they needed treatment. The NNRT person may be “in
denial,” unwilling, or unable to give up an addictive substance. Such
individuals may not be “in denial” but simply did not perceive their
AOD use as causing a problem serious enough to require treatment.
Finally, NNRT individuals may believe that they can recover on their
own without any intervention or expert help. Scholars who studied
the problem point out that the “majority of alcoholics who recover
do so without the benefit of treatment” (Russell, Peirce, Chan,
Wieczorek, Moscato, & Nochajski, 2001, p. 1417; See also Russell,
et al.; Sobell, Klingemann, Toneatto, Sobell, Agrawal, & Leo, 2001,
who discuss the issue of “natural recovery”).
On the other hand, we should bear in mind that a substantial
number of people with AOD problems realize they need treatment
yet are unable to obtain it. The 2003-2004 NSDUH data (SAMHSA,
2005a) shed light on the reasons why Americans who needed, “felt
they needed,” and “made an effort to get” did not get treatment.


42.5% of these individuals cited “cost/insurance barriers” as
the primary reason they cannot obtain treatment.

Other reasons included


“not ready to stop using” (25.3%), “access barriers other than
cost” (21.5%), “stigma” (17.8%), “did not know where to go
for treatment” (9.8%), “did not feel need for treatment/could
handle the problem without treatment” (8.6%), “did not have
time” (5.4%), and “treatment would not help” (1.0%).

(Note: This data described the population nationwide. The specific
data for individual States were not available. Although we can
assume that most States, including Nevada, may follow the national

trend in this regard, it would be more scientific if the State could
conduct its own study to verify the results.)
Of particular concern are people prevented from obtaining
treatment due to insurance barriers. Close to half of the people who
needed and wanted treatment did not get treatment because of
cost/insurance barriers. According to the 2004 NSDUH findings
(SAMHSA, 2005b),




About 43.1% of persons who received treatment at an AOD
specialty facility reported that they used their own savings/
earnings to pay for as a source to pay for their treatment.
Other sources of payment included “private health insurance”
(38%), “Medicaid” (29%), “Medicare” (22.8%), “public
assistance other than Medicaid” (22.4%), and “relying on
family members” (21.2%). A person may use one or more of
these sources for payments of AOD specialty treatment.

Since public-funded AOD treatment programs are still relatively
scarce, it is not uncommon for an applicant seeking public-funded
AOD treatment to be put on a waiting list. One example is that in
Southern Nevada only one residential facility for substance-abusing
(pregnant) women and their infants/young children exists and the
facility can only take 15 families at a time. The delay in receiving
treatment and service may create long-term negative outcomes for
the applicant. Empirical studies have shown that the longer the
delay between a client’s initial inquiry about treatment and the
actual appointment scheduled, the less likely the client would keep
the appointment (Festinger, Lamb, Kountz, Kirby, & Marlowe, 1995;
Orne & Boswell, 1991). According to Nevada BADA (Towle, et al.,
2004),
1,946 clients were on waiting lists for an average of 28 days during
the state fiscal year 2004. Among them, 99 clients received
“support services in the interim” because they were in categories
that qualified them as priority populations (i.e., intravenous drug
users and/or pregnant women) (See Appendix 3 for detail).
There is a conflict here between the shortage of facilities and
personnel in Nevada AOD treatment centers and the need to

provide a lengthy enough treatment required for a positive outcome
(estimated to be 3 months on average). As a result, AOD
professionals have to choose between extending the length of stay
to assure a positive outcome and delaying admittance of new
patients waiting for treatment.
Prospects for the Future and Policy Considerations
Increase State Funding for Drug Abuse Treatment
The social costs caused by AOD abuse are enormous. While we
cannot eradicate the problem, we can alleviate some of the
suffering it causes to people with addictions and their families and
contain the damage it inflicts on our communities. As Susan Ettner
showed in a recent UCLA study that she led, every $1 invested in
AOD treatment saves society $7 (Join Together, 2005). Other
studies suggest that for every $1 invested in AOD
treatment/prevention, society saves between $5.85 and $9.6
(NIDA, 2002). “Spending taxpayer dollars on substance-abuse
treatment appears to be a wise investment,” Ettner points out (Join
Together).


Based on a solid consensus among scholars and AOD
professionals, we recommend that the Nevada legislature
declare funding substance abuse treatment a priority on both
humanistic and economic grounds.

Support Public Substance Abuse Treatment Programs
Many drug abusers come from lower socio-economic strata and can
obtain help only from public-funded treatment programs. However,
these programs are often strapped for resources. These chronic
shortages delay urgently needed treatments. As the NIDA web site
states: “Because individuals who are addicted to drugs may be
uncertain about entering treatment, taking advantage of
opportunities when they are ready for treatment is crucial. Potential
treatment applicants can be lost if treatment is not immediately
available or is not readily accessible.” Research confirms that the
longer the time between an AOD client’s inquiry about treatment
and the actual scheduling date of an appointment, the less likely the

client is to keep the appointment (Festinger, et al., 1995; Orne &
Boswell, 1991). Hence, we urge that


Nevada state officials should shore up, and where possible
expand, drug abuse treatment facilities to assure a timely
delivery of much needed services.

Mount a State-Wide Drug Abuse Awareness Campaign
Over 90% of people who need but do not receive AOD treatment
feel they do not need it. To narrow the treatment gap, we need to
raise awareness in at-risk groups and the Nevada population as a
whole about the treatable nature of drug addiction and the pubic
facilities available to help those in need. Many of those who need
but do not receive substance abuse treatment may end up in the
criminal justice and child welfare systems or in emergency rooms or
be involved with primary medical care. One way we can minimize
the AOD treatment gap is to increase the effectiveness of AOD
screening and referrals by professionals in the criminal justice, child
welfare, and health care systems. Studies show that primary
medical care and child welfare workers are often poorly trained in
screening and referring their clients for specialty AOD treatment
(Dore, Doris, & Wight, 1995; McGlynn, et al., 2003; Meara & Frank,
2005; Young, Gardner, & Dennis, 1998). We recommend that


The Nevada government should play a more central role in
promoting drug abuse education programs and increasing the
community’s drug abuse awareness, as well as in enhancing
the AOD screening and referral competence among
professionals of the various systems that often encounter
clients who need, but do not feel they need, AOD treatment.

In addition, empirical evidence shows that “Motivational
Interviewing” (MI)/”Motivational Enhancement Therapy” (MET) is
particularly effective in promoting clients’ entry to and engagement
in intensive AOD treatment (Carroll, Libby, Sheehan, & Hyland,
2001; Dunn, Deroo, & Rivara, 2001). We recommend that


Professionals in the AOD treatment field, as well as in the
above-mentioned other systems, must be trained to in the

latest techniques that promote the clients’ entry in the
treatment facilities (See Miller and Rollnick [2002] for details
about MI/MET).
Emphasize AOD Treatment Program Accountability
and Devise Programs Targeting Special Populations
NIDA has formulated 13 evidence-based principles of “effective
treatment,” which state among other things that treatment needs to
be readily available; that effective treatment attends to multiple
needs of the individual, not just his or her drug use; that remaining
in treatment for an adequate period of time is critical for treatment
effectiveness, and that addicted or drug-abusing individuals with
coexisting mental disorders should have both disorders treated in an
integrated way (see Appendix A for details). For the past three
years Nevada BADA has required, and provided training for, NIDA's
13 principles in all their funded treatment programs. We believe
that


BADA should continue to require training in NIDA 13 principles
and extend this requirement to non-BADA funded providers.

SAMHSA’s Treatment of Improvement Protocol (TIP) #2 spells out
guidelines for those working with pregnant women involved with
substance abuse. TIP #32 offers advice to those dealing with
adolescents, and TIP #33 focuses on “Treatment for Stimulant Use
Disorders,” including strategies for dealing with rural residents, and
so on. The SAMHSA Center for Substance Abuse Treatment-funded
Mountain West Addiction Technology Transfer Center and the
SAMHSA Center for Substance Abuse Prevention-funded Western
Region Center for the Application of Prevention Technologies are
two other resources from which practitioners can benefit for AOD
treatment/prevention program development and implementation.
We recommend that


Nevada professionals working in the drug abuse treatment
area must fine-tune their programs to deliver more efficient
services to special populations.

Fund More AOD Research

Nevada has an extremely, perhaps even uniquely, diverse
population, which resides in vast rural regions, medium-size
metropolitan areas, and a world class metropolis that bills itself as
the world capital of entertainment. People residing in these diverse
areas are bound to have diverse AOD treatment needs. To deliver
effective services to these regions, the state should help organize
and fund AOD research that promises to illuminate specific needs of
each population.
Conclusion
There is good and bad news for the Silver State when it comes to its
AOD prevalence and treatment gap. The good news is that Nevada
moved from the worst tier in 2002 to the middle tier in 2002-2003
in the illicit drug use and treatment gap categories. The bad news is
that Nevada moved from the middle tier in 2002 to the secondworst tier in 2002-2003 in the area of alcohol use and alcohol
treatment. The 2002 and 2002-2003 data show that, overall,
Nevada moved back and forth between the middle, the secondworst, and worst tiers for its AOD prevalence and treatment gap
rates. Our state’s primary goal should be reversing the trend and
moving Nevada to top three tiers in the drug abuse and treatment
categories. To achieve this goal, we need to move on several fronts:
(a) increase the state funding, (b) better use the available
resources, and (c) devise innovated strategies for preventing drug
abuse and reaching out to people with addiction.
There are several other important tasks facing our state. One is
addressing the epidemics of Methamphetamine/ amphetamines use,
which has become one of the primary illicit drugs in Nevada and
which has had an especially adverse impact on Nevada women,
youth, and residents of rural areas. Many of those with a serious
meth dependency hail from lower socio-economic strata and lack
resources to combat the addiction.
It is also imperative to provide assistance that meets the needs of
specific gender and age groups. The Nevada youth, who were
among the groups with the highest marijuana use prevalence and
incidence (new users) in the U.S., also require special attention. We

need innovative, youth-specific prevention and treatment programs
to combat drug abuse and addiction among the Nevada youth.
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Community Resources
Bureau of Alcohol and Drug Abuse, Certified Treatment
Programs . BADA Phone numbers: North – Tel. 775-684-4190;
South – Tel. 702-486-8250. BADA Web site
address: http://health2k.state.nv.us/BADA/.
Battle Mountain, Vitality Center, Battle Mountain. Contact Main
Office in Elko, Battle Mountain NV 89820. Tel. 775-738-8004.
American Comprehensive Counseling Services, 625 Fairview
St., Ste. 125, Carson City, NV 89701. Tel. 775-883-4325.
Carson Mediation and Counseling Center, 755 N. Roop St., Ste.
108, Carson City, NV 89701. Tel. 775-887-0303.
Community Counseling Center-CC (Counseling in Spanish), 205
S. Pratt St., Carson City, NV 89701-5240. Tel. 775-882-3945.
Jackie Rasor Evaluation Center, 116 East 7th St., Ste. 3, Carson
City, NV 89701. Tel. 775-883-2237.
Cinper Evaluation Center, 2874 N. Carson St., #215, Carson City,
NV 89706. Tel. 775-885-7717.
John Glenn Evaluation Center (Counseling in Spanish), 1000 E.
William St., #111, Carson City, NV 89703. Tel. 775-882-4340.
Dayton , Lyon Council on AOD, 50 River St., Dayton , NV 89403.
Tel. 775-463-6597.

Elko County Juvenile Probation Department , 665 W. Silver St.,
Elko , NV 89801. Tel. 775-753-4603. Vitality Center (Counseling in
Spanish). 3740 E. Idaho St., Elko, NV 89801-4611. Tel. 775-7388004.
Mental Health and Developmental Services, 1665 Ave. F, Ely,
NV 89301. Tel. 775-289-1671.
Vitality Center – Eureka. Contact Main Office in Elko, Eureka, NV
89316. Tel. 775-738-8004.
New Frontier (Counseling in Spanish), 165 N. Carson St., Fallon,
NV 89406. Tel. 775-423-1412.
Lyon Council on AOD (Counseling in Spanish), 200 E. Main St.,
Fernley, NV 89408. Tel. 775-463-6597.
Mental Health and Developmental Services, 1000 ‘C’ St.,
Hawthorne, NV 89415. Tel. 775-945-3387.
ABC Therapy, 7 Water St., Ste. A. Henderson, NV 89015. Tel. 702568-9971.
Clark County Department of Family Services – Family
Preservation, 522 E. Lake Mead Dr. Henderson, NV 89015. Tel.
702-455-8006.
Henderson Municipal Court Program, 243 Water St., Lower
Level, Henderson, NV 89015. Tel. 702-267-1350.
New Life Medical Center, 704 W. Sunset Rd., Ste. B-9.
Henderson, NV 89015. Tel. 702-558-8600.
Westcare @ Safehouse, 921 American Pacific, Ste. 300,
Henderson, NV 89015. Tel. 702-383-4044.
Las Vegas , ABC Therapy (Counseling in Spanish), 740 N. Eastern
Ave., Ste. 110, Las Vegas, NV 89101. Tel. 702-598-2020.
Accessible Space – NCEP, 6375 W. Charleston Blvd., #L-200, Las
Vegas, NV 89146. Tel. 702-259-1903.

Adelson Clinic (Counseling in Spanish), 3661 S. Maryland Pkwy.,
Ste. 64, Las Vegas, NV 89109-3003. Tel. 702-735-7900.
Bridge Counseling Associates (Counseling in Spanish), 1701 W.
Charleston Blvd., Ste. 400, Las Vegas, NV 89102-2320. Tel. 702474-6450.
Center for Behavioral Health (Speaks Spanish), 3050 E. Desert
Inn Rd., Ste. 116, Las Vegas, NV 89121. Tel. 702-796-0660.
Center for Behavioral Health, Inc., 721 E. Charleston, #6, Las
Vegas, NV 89104. Tel. 702-382-6262.
Center for Independent Living, 1417 Las Vegas Blvd. N., Las
Vegas, NV 89101-1115. Tel. 702-385-3776.
Choices Group, Inc. , 800 S. Valley View Blvd., Las Vegas, NV
89107. Tel. 702-252-8342.
Clark County Court Education Program (Counseling in Spanish),
310 S. 3rd St., Rm. 212, Las Vegas, NV 89155. Tel. 702-455-4718.
Community Counseling Center-LV (Counseling in Spanish), 1120
Almond Tree Ln., Ste. 207, Las Vegas, NV 89104-3229. Tel. 702369-8700.
Economic Opportunity Board, 522 W. Washington, Las Vegas, NV
89106-3327, tel. 702-648-0663.
Family & Child Treatment of Southern Nevada (Counseling in
Spanish), 1050 South Rainbow Blvd., Las Vegas, NV 89145. Tel.
702-258-5855.
Human Resource Development Institute (Counseling in
Spanish), 3365 E. Flamingo, Ste. 10, Las Vegas, NV 89121. Tel.
702-933-1156.
Las Vegas Indian Center, Inc ., 2300 W. Bonanza Rd., Las
Vegas, NV 89106. Tel. 702-647-5842.

Las Vegas Municipal Court Evaluation Center (Counseling in
Spanish), 2917 W. Washington, Las Vegas, NV 89107. Tel. 702229-2252.
Las Vegas Recovery Center, 3371 N. Buffalo Dr., Las Vegas, NV
89129. Tel. 702-515-1373.
Legal Rehab Services (Counseling in Spanish), 2061 E. Sahara
Ave., Las Vegas, NV 89104. Tel. 702-732-0214.
Mesa Family Counseling, 1000 S. Third St., Ste. F, Las Vegas, NV
89101. Tel. 702-383-6001.
Nevada Treatment Center (Counseling in Spanish), 1721 E.
Charleston Blvd., Las Vegas, NV 89104-1902. Tel. 702-382-4226.
New Choices, Inc., 2121 Western Ave., Ste. A-1, Las Vegas, NV
89102. Tel. 702-383-9777.
New Life Medical Center, 1800 Industrial Rd., Ste. 208, Las
Vegas, NV 89102. Tel. 702-474-4104.
Options Evaluation Center, 4528 W. Craig Rd., Ste. 150, Las
Vegas, NV 89032. Tel. 702-646-4736.
WestCare Nevada (Counseling in Spanish), 5659 Duncan Drive,
Las Vegas, NV 89130. Tel. 702-385-2020.
Westcare-Laughlin, 3650 South Pointe Circle, Ste. 205, Laughlin,
NV 89028. Tel. 702-299-142.
New Frontier (Counseling in Spanish), Contact New Frontier in
Fallon, Lovelock, NV 89419. Tel. 775-423-1412.
Mental Health and Developmental Services, 61 N. Willow , Ste.,
4, Mesquite, NV 89027. Tel. 702-346-4696.
Community Counseling Center, 1624 Library Ln., Ste. C, Minden,
NV 89423. Tel. 775-882-3945.

Nevada Medical Systems, 2516 E. Lake Mead Blvd., North Las
Vegas, NV 89036. Tel. 702-399-1600.
North Las Vegas Awareness School, Inc. (Counseling in
Spanish), 2934 Van Der Meer St., North Las Vegas, NV 89030. Tel.
702-642-9866.
Salvation Army, 211 Judson Ave., North Las Vegas, NV 890305642. Tel. 702-399-2769.
Owyhee, Shoshone Paiute Tribes of Duck Valley Reservation, PO
Box 130 , Owyhee, NV 89832. Tel. 775-757-2415, ext. 239.
Mental Health and Developmental Services, 1840 S. Pahrump
Valley Blvd., Ste. A, Pahrump, NV 89048. Tel. 775-751-7406.
American Therapeutic Association (Counseling in Spanish),
2105 Cappuro Way, Ste. 100, Sparks, NV 89431-8586. Tel. 775355-7734.
Brennan Evaluations (Counseling in Spanish), 275 Hill St., Ste.
200, Reno, NV 89501. Tel. 775- 329-5006.
Bristlecone Family Resources – Northstar, 480 Galletti Way,
Bldgs. 3&4, Sparks, NV 89431. Tel. 775-786-6563.
Bristlecone Family Resources – Sagewind (Counseling in
Spanish), 1725 S. McCarran Blvd., Sparks, NV 89431. Tel. 775-9541400.
Center for Behavioral Health, 160 Hubbard Way, Ste. A, Reno,
NV 89502. Tel. 775-829-4472.
Evaluation Center, 150 N. Center St., #318, Reno, NV 89502. Tel.
775-240-5251.
Evergreen Evaluation and Education Center (Counseling in
Spanish), 741 Greenbrae Drive, Sparks, NV 89431. Tel. 775-3581101.

Family Counseling Services of No. NV (Counseling in Spanish),
575 E. Plumb Ln., #100, Reno, NV 89502-3543. Tel. 775-329-0623,
ext. 103.
Huntridge Counseling, Inc., PO Box 12541, Reno, NV 89510, Tel.
775-233-8426.
Joann Dwight Evaluation Center, Inc., 1000 Bible Way, #46,
Reno, NV 89503. Tel. 775-787-7378.
Lynne Daus Evaluation Center, 421 Hill St., #3, Reno, NV 89501.
Tel. 775-348-7550.
Reno Sparks Tribal Health Center (Counseling in Spanish), 34
Reservation Rd., Reno, NV 89502-1588. Tel. 775-329-5162.
Reno Treatment Center, 750 Kuenzli St., Reno, NV 89502. Tel.
775-333-5233.
Ridge House, 900 W. First St., Ste. 200, Reno, NV 89503. Tel.
775-322-8941.
Star Evaluation, 150 N. Center St., #204, Reno, NV 89502. Tel.
775-544-3550.
Step 1, Inc., 1015 N. Sierra St., Reno, NV 89503. Tel. 775-3223576.
Step 2, Inc., 3695 Kings Row, Reno, NV 89503. Tel 775-787-9411,
ext. 202.
S. Lake Tahoe Sierra Recovery Center, 972-B Tallac Ave., S.
Lake Tahoe, CA 96150-7995. Tel. 530-541-5190.
Silver Springs, Lyon Council on AOD (Counseling in Spanish),
2475 Fort Churchill/McAtee, Bldg. Silver Springs, NV 89429. Tel.
775-463-6597.
Mental Health and Developmental Services (Counseling in
Spanish), 825 S. Main St., Tonopah, NV 89049. Tel. 775-482-6742.

Lyon Council on AOD (Community Chest) (Counseling in Spanish),
991 South C St., Virginia City, NV 89440. Tel. 775-847-9311.
Vitality Center (Great Basin), 915 Wells, Ste. 3, Wendover, NV
89832. Tel. 775-664-3421.
Substance Abuse Counseling and Evaluation Services, 737 E.
Fairgrounds Rd., Winnemucca, NV 89446. Tel. 775-442-0537.
Vitality Center (Silver Sage), 530 Melarkey St., Ste. 202,
Winnemucca, NV 89445. Tel. 775-623-3626.
Lyon Council on AOD (Counseling in Spanish), 215 W. Bridge St.,
#8, Yerington, NV 89447-0981. Tel. 775-463-6597.
This report has been prepared by Dr. An-Pyng Sun, LCSW,
Associate Professor, School of Social Work, Greenspun
College of Urban Affairs, University of Nevada Las Vegas,
4505 Maryland Parkway, Box 455032, Las Vegas, NV 891545032. Telephone: 702-895-4349. Email: anpyng.sun@unlv.edu; and Larry L. Ashley, EdS, LADC,
Addictions Specialist, Department of Counseling, Greenspun
College of Urban Affairs, University of Nevada Las Vegas ,
4505 Maryland Parkway, Box 453045, Las Vegas, NV 891543045. Telephone: 702-895-3935.
Email: larry.ashley@unlv.edu.
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Supplementary Materials
Bureau of Alcohol and Drug Abuse - Important Contact
Information
Information Only
National Clearinghouse for Alcohol and Drug Info. 1(800) 729-6686
N/A N/A
Nevada Substance Abuse Resource Center N/A (775) 784-6336
(702) 385-0684
Poison Information N/A (775) 982-4129 (702) 732-4989
Referral and Information
AIDS (CDC National AIDS/HIV Hotline) 1 (800) 342-2437 N/A N/A
AIDS-Teen Line 1 (800) 234-8336 N/A N/A
Bureau of Alcohol and Drug Abuse N/A (775) 684-4190 (702) 4868250
Crisis Mental Health Unit N/A (775) 877-4673 (702) 486-8020
Juvenile Court Services (Abuse and Neglect) N/A (775) 328-2777
(702) 399-0081
National Council on Compulsive Gambling 1 (800) 522-4700 N/A
N/A
National Domestic Violence Hotline 1 (800) 799-7233 N/A N/A
National Mental Health Association 1 (800) 969-6642 N/A
N/A National Youth Crisis Hotline 1 (800) 448-4663 N/A N/A
Rape Crisis Center 1 (800) 752-4528 N/A N/A
Substance Abuse Help Line (Crisis Call Center) 1 (800) 450-9530
N/A N/A
Suicide Prevention Center 1 (800) 992-5757 N/A N/A
Youth Runaway Emergency Shelter 1 (800) 448-4663 N/A N/A
Self Help
Alanon and Alateen Groups N/A (775) 348-7103 (702) 615-9494
Alcoholics Anonymous N/A (775) 355-1151 (702) 598-1888
Gamblers Anonymous N/A (775) 356-8070 (702) 364-2625
Narcotics Anonymous N/A (775) 322-4811 (702) 369-3362

Table 1.
Primary Substance Abuse at Admission (Nevada vs. National)

Alcohol w/
Cocaine
Alcohol
Cocaine
AmphetSecondary MarijuanaHeroin
(other
Others Tot
Only
(smoked)
amines
Drug
route)
National
23.6%
19.3%
15.2% 15.1%
9.4%
3.5%
6.6%
7.4% 100
(2002)
Nevada
26.8%
12.8%
14.4%
6.6%
7.9%
2.5%
26.9% 2.0% 100
(2002)
Nevada
25.9%
13.2%
13.2%
5.9%
8.3%
2.3%
27.8% 3.3% 100
(2003)
Nevada
26.7%
13.1%
12.4%
5.6%
7.6%
2.1%
28.8% 3.8% 100
(2004)
Source: SAMHSA, Treatment Episode Data Set (TEDS). Available at
http://wwwdasis.samhsa.gov/webt/quicklink/US02.htm
http://wwwdasis.samhsa.gov/webt/quicklink/NV02.htm- /NV04.htm

Table 2.
Historical Trend of Primary Substance Abuse at Admission in
Nevada (1992 – 2004).
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100
35.5% 22.0% 11.9% 4.0%
6.2% 11.6% 5.3% 3.7%
%
100
30.0% 24.3%
9.6%
3.9%
7.9%
8.2% 11.3% 2.3%
%
100
27.2% 21.2% 12.1% 2.6%
7.8%
9.4% 17.8% 2.0%
%
100
27.1% 17.6%
9.6%
2.3%
9.4%
8.7% 21.5% 3.9%
%
100
30.7% 17.9% 10.1% 2.1%
10.4% 10.2% 17.1% 1.6%
%
100
29.0% 14.7% 10.5% 1.6%
10.6% 10.0% 22.2% 1.3%
%
100
27.6% 15.4%
9.9%
2.3%
10.2% 11.5% 21.6% 1.6%
%
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28.3%

17.0%

10.3%

2.2%

10.7%

9.0% 20.8% 2.0%

25.6%

16.5%

10.3%

2.9%

13.7%

7.3% 22.3% 1.4%

28.9%

12.5%

10.3%

2.6%

12.8%

7.2% 23.7% 2.0%

26.8%

12.8%

7.9%

2.5%

14.4%

6.6% 26.9% 2.0%

25.9%

13.2%

8.3%

2.3%

13.2%

5.9% 27.8% 3.3%

26.7%

13.1%

7.6%

2.1%

12.4%

5.6% 28.8% 3.8%

100
%
100
%
100
%
100
%
100
%
100
%

Source: SAMHSA, Treatment Episode Data Set (TEDS). Available at:
http://wwwdasis.samhsa.gov/webt/quicklink/NV92.htm - /NV04.htm

Table 3.
Substance Abuse Treatment Admissions by Primary
Substance of Abuse,
According to Geographic Areas
Club
Cocaine
Amphet./
Marijuana/
Drugs/
Alcohol
(including
Opioids
Other
Meth
Hashish
Hallucinocrack)
gens
Clark
36.99%
County
Washoe
39.67%
County
Rural
49.40%
Nevada
Carlson
66.06%
City

22.35%

18.03%

11.06%

10.38%

0.65%

0.54%

29.11%

9.33%

14.19%

6.94%

0.20%

0.56%

27.37%

2.31%

17.42%

2.15%

0.40%

0.95%

17.94%

1.95%

12.38%

1.11%

0.00%

0.56%

Source: 2003 Needs Assessment: Bureau of Alcohol and Drug Abuse,
Nevada State Health Division.
Available: http://health.2k.state.nv.us/BADA/2003/NeedsAssessment.pdf.

Appendix A
The non-priority populations of the 1,946 clients most likely did not receive any services,
including the “support services in the interim,” during the waiting period. The purposes of
the interim services are to reduce the adverse health effects of such abuse, promote the
health of the individual, and reduce the risk of transmission of disease. At a minimum,
interim services include counseling and education about HIV and tuberculosis (TB), about
the risks of needle-sharing, the risks of transmission to sexual partners and infants, and
about steps that can be taken to ensure that HIV and TB transmission does not occur, as
well as referral for HIV or TB treatment services if necessary. For pregnant women, interim
services also include counseling on the effects of alcohol and drug use on the fetus, as well
as referral for prenatal care.

Appendix B
NIDA’s 13 Principles of Effective Treatment











No single treatment is appropriate for all individuals. Matching treatment settings,
interventions, and services to each individual's particular problems and needs is
critical to his or her ultimate success in returning to productive functioning in the
family, workplace, and society.
Treatment needs to be readily available. Because individuals who are addicted to
drugs may be uncertain about entering treatment, taking advantage of opportunities
when they are ready for treatment is crucial. Potential treatment applicants can be
lost if treatment is not immediately available or is not readily accessible.
Effective treatment attends to multiple needs of the individual, not just his or her
drug use. To be effective, treatment must address the individual's drug use and any
associated medical, psychological, social, vocational, and legal problems.
An individual's treatment and services plan must be assessed continually and
modified as necessary to ensure that the plan meets the person's changing needs. A
patient may require varying combinations of services and treatment components
during the course of treatment and recovery. In addition to counseling or
psychotherapy, a patient at times may require medication, other medical services,
family therapy, parenting instruction, vocational rehabilitation, and social and legal
services. It is critical that the treatment approach be appropriate to the individual's
age, gender, ethnicity, and culture.
Remaining in treatment for an adequate period of time is critical for treatment
effectiveness. The appropriate duration for an individual depends on his or her
problems and needs (see pages 11-49). Research indicates that for most patients,
the threshold of significant improvement is reached at about 3 months in treatment.
After this threshold is reached, additional treatment can produce further progress
toward recovery. Because people often leave treatment prematurely, programs
should include strategies to engage and keep patients in treatment.
Counseling (individual and/or group) and other behavioral therapies are critical
components of effective treatment for addiction. In therapy, patients address issues
of motivation, build skills to resist drug use, replace drug-using activities with
constructive and rewarding nondrug-using activities, and improve problem-solving
abilities. Behavioral therapy also facilitates interpersonal relationships and the
individual's ability to function in the family and community. ( Approaches to Drug
Addiction Treatment section discusses details of different treatment components to
accomplish these goals.)















Medications are an important element of treatment for many patients, especially
when combined with counseling and other behavioral therapies. Methadone and levoalpha-acetylmethadol (LAAM) are very effective in helping individuals addicted to
heroin or other opiates stabilize their lives and reduce their illicit drug use.
Naltrexone is also an effective medication for some opiate addicts and some patients
with co-occurring alcohol dependence. For persons addicted to nicotine, a nicotine
replacement product (such as patches or gum) or an oral medication (such as
bupropion) can be an effective component of treatment. For patients with mental
disorders, both behavioral treatments and medications can be critically important.
Addicted or drug-abusing individuals with coexisting mental disorders should have
both disorders treated in an integrated way. Because addictive disorders and mental
disorders often occur in the same individual, patients presenting for either condition
should be assessed and treated for the co-occurrence of the other type of disorder.
Medical detoxification is only the first stage of addiction treatment and by itself does
little to change long-term drug use. Medical detoxification safely manages the acute
physical symptoms of withdrawal associated with stopping drug use. While
detoxification alone is rarely sufficient to help addicts achieve long-term abstinence,
for some individuals it is a strongly indicated precursor to effective drug addiction
treatment ( see Drug Addiction Treatment Section).
Treatment does not need to be voluntary to be effective. Strong motivation can
facilitate the treatment process. Sanctions or enticements in the family, employment
setting, or criminal justice system can increase significantly both treatment entry
and retention rates and the success of drug treatment interventions.
Possible drug use during treatment must be monitored continuously. Lapses to drug
use can occur during treatment. The objective monitoring of a patient's drug and
alcohol use during treatment, such as through urinalysis or other tests, can help the
patient withstand urges to use drugs. Such monitoring also can provide early
evidence of drug use so that the individual's treatment plan can be adjusted.
Feedback to patients who test positive for illicit drug use is an important element of
monitoring.
Treatment programs should provide assessment for HIV/AIDS, hepatitis B and C,
tuberculosis and other infectious diseases, and counseling to help patients modify or
change behaviors that place themselves or others at risk of infection. Counseling can
help patients avoid high-risk behavior. Counseling also can help people who are
already infected manage their illness.
Recovery from drug addiction can be a long-term process and frequently requires
multiple episodes of treatment. As with other chronic illnesses, relapses to drug use
can occur during or after successful treatment episodes. Addicted individuals may
require prolonged treatment and multiple episodes of treatment to achieve long-term
abstinence and fully restored functioning. Participation in self-help support programs
during and following treatment often is helpful in maintaining abstinence.
Source: National Institute of Drug Abuse, available
at http://www.nida.nih.gov/PODAT/PODAT1.html

*This report stems from the Justice & Democracy forum on the Leading Social
Indicators in Nevada that took place on November 5, 2004, at the William S. Boyd

School of Law. The report, the first of its kind for the Silver State, has been a
collaborative effort of the University of Nevada faculty, Clark County professionals,
and state of Nevada officials. The Social Health of Nevada report was made possible
in part by a Planning Initiative Award that the Center for Democratic Culture received
from the UNLV President's office for its project "Civic Culture Initiative for the City
of Las Vegas." Individual chapters are brought on line as they become avaialble. For
further inquiries, please contact authors responsible for individual reports or email
CDC Director, Dr. Dmitri Shalin shalin@unlv.nevada.edu.

